Takeda Pharmaceutical Company LimitedTAK

Where TAK's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$18.60+0.34 (+1.86%)Previous close
NYSEHealthcare

TAK P/E ratio: current value, 10-year range and year-by-year history

51.0Historically pricey

TAK's p/e ratio is higher than 82% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
TAK P/E ratio historyTAK P/E ratio from Sep 2023 to Sep 2026: low 22.33, high 239.63, latest 50.96.4.9467.96130.98193.99257.01Sep 23Apr 24Nov 24Jul 25Feb 26Sep 26med 45.17

TAK P/E ratio by year

Yearly range of TAK’s p/e ratio from 2016 to 2026. Over the full period it ranged from -173.2 to 397.4, averaging 43.8.

TAK P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202639.856.982.051.0
202531.091.9239.668.5
202422.337.846.532.0
202321.526.137.833.1
202211.324.332.130.0
20219.918.037.711.2
2020-173.292.5397.432.7
2019-166.251.2105.7-166.2
201815.721.426.221.1
201723.827.533.226.7
201621.323.325.522.1

Get notified when TAK P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is TAK P/E ratio High or Low Right Now?

Takeda Pharmaceutical Company Limited's P/E ratio is currently 51.0, which is historically pricey relative to its 10-year historical range. The 10-year median P/E ratio for TAK is approximately 28.2. See all TAK valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.